Eprodisate - CAS 21668-77-9

Eprodisate is a novel compound specifically developed to disrupt the interactions between amyloidogenic proteins and glycosaminoglycans, effectively impeding the polymerization of amyloid fibrils and their deposition in tissues. This compound shows potential for delaying the advancement of AA amyloidosis-related renal disease and could apply to various forms of amyloidosis.

Beta Amyloid, Others

Others, Neuroscience

21582

C3H8O6S2

204.22

OS(=O)(=O)CCCS(O)(=O)=O

-20°C

Ice Packs

Small Compound